Idiopathic Hypersomnia Treatment and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Idiopathic Hypersomnia Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Idiopathic Hypersomnia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Idiopathic Hypersomnia Treatment Overall Market Size
2.1 Global Idiopathic Hypersomnia Treatment Market Size: 2022 VS 2030
2.2 Global Idiopathic Hypersomnia Treatment Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Idiopathic Hypersomnia Treatment Players in Global Market
3.2 Top Global Idiopathic Hypersomnia Treatment Companies Ranked by Revenue
3.3 Global Idiopathic Hypersomnia Treatment Revenue by Companies
3.4 Top 3 and Top 5 Idiopathic Hypersomnia Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Idiopathic Hypersomnia Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Idiopathic Hypersomnia Treatment Players in Global Market
3.6.1 List of Global Tier 1 Idiopathic Hypersomnia Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Idiopathic Hypersomnia Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Idiopathic Hypersomnia Treatment Market Size Markets, 2022 & 2030
4.1.2 Stimulant Medications
4.1.3 Non-Stimulant Wake-Promoting Medications
4.1.4 Sodium Oxybate
4.2 By Type - Global Idiopathic Hypersomnia Treatment Revenue & Forecasts
4.2.1 By Type - Global Idiopathic Hypersomnia Treatment Revenue, 2018-2023
4.2.2 By Type - Global Idiopathic Hypersomnia Treatment Revenue, 2024-2030
4.2.3 By Type - Global Idiopathic Hypersomnia Treatment Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Idiopathic Hypersomnia Treatment Market Size, 2022 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Idiopathic Hypersomnia Treatment Revenue & Forecasts
5.2.1 By Application - Global Idiopathic Hypersomnia Treatment Revenue, 2018-2023
5.2.2 By Application - Global Idiopathic Hypersomnia Treatment Revenue, 2024-2030
5.2.3 By Application - Global Idiopathic Hypersomnia Treatment Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Idiopathic Hypersomnia Treatment Market Size, 2022 & 2030
6.2 By Region - Global Idiopathic Hypersomnia Treatment Revenue & Forecasts
6.2.1 By Region - Global Idiopathic Hypersomnia Treatment Revenue, 2018-2023
6.2.2 By Region - Global Idiopathic Hypersomnia Treatment Revenue, 2024-2030
6.2.3 By Region - Global Idiopathic Hypersomnia Treatment Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Idiopathic Hypersomnia Treatment Revenue, 2018-2030
6.3.2 US Idiopathic Hypersomnia Treatment Market Size, 2018-2030
6.3.3 Canada Idiopathic Hypersomnia Treatment Market Size, 2018-2030
6.3.4 Mexico Idiopathic Hypersomnia Treatment Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Idiopathic Hypersomnia Treatment Revenue, 2018-2030
6.4.2 Germany Idiopathic Hypersomnia Treatment Market Size, 2018-2030
6.4.3 France Idiopathic Hypersomnia Treatment Market Size, 2018-2030
6.4.4 U.K. Idiopathic Hypersomnia Treatment Market Size, 2018-2030
6.4.5 Italy Idiopathic Hypersomnia Treatment Market Size, 2018-2030
6.4.6 Russia Idiopathic Hypersomnia Treatment Market Size, 2018-2030
6.4.7 Nordic Countries Idiopathic Hypersomnia Treatment Market Size, 2018-2030
6.4.8 Benelux Idiopathic Hypersomnia Treatment Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Idiopathic Hypersomnia Treatment Revenue, 2018-2030
6.5.2 China Idiopathic Hypersomnia Treatment Market Size, 2018-2030
6.5.3 Japan Idiopathic Hypersomnia Treatment Market Size, 2018-2030
6.5.4 South Korea Idiopathic Hypersomnia Treatment Market Size, 2018-2030
6.5.5 Southeast Asia Idiopathic Hypersomnia Treatment Market Size, 2018-2030
6.5.6 India Idiopathic Hypersomnia Treatment Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Idiopathic Hypersomnia Treatment Revenue, 2018-2030
6.6.2 Brazil Idiopathic Hypersomnia Treatment Market Size, 2018-2030
6.6.3 Argentina Idiopathic Hypersomnia Treatment Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Idiopathic Hypersomnia Treatment Revenue, 2018-2030
6.7.2 Turkey Idiopathic Hypersomnia Treatment Market Size, 2018-2030
6.7.3 Israel Idiopathic Hypersomnia Treatment Market Size, 2018-2030
6.7.4 Saudi Arabia Idiopathic Hypersomnia Treatment Market Size, 2018-2030
6.7.5 UAE Idiopathic Hypersomnia Treatment Market Size, 2018-2030
7 Idiopathic Hypersomnia Treatment Companies Profiles
7.1 Takeda Pharmaceutical
7.1.1 Takeda Pharmaceutical Company Summary
7.1.2 Takeda Pharmaceutical Business Overview
7.1.3 Takeda Pharmaceutical Idiopathic Hypersomnia Treatment Major Product Offerings
7.1.4 Takeda Pharmaceutical Idiopathic Hypersomnia Treatment Revenue in Global Market (2018-2023)
7.1.5 Takeda Pharmaceutical Key News & Latest Developments
7.2 Teva Pharmaceutical Industries
7.2.1 Teva Pharmaceutical Industries Company Summary
7.2.2 Teva Pharmaceutical Industries Business Overview
7.2.3 Teva Pharmaceutical Industries Idiopathic Hypersomnia Treatment Major Product Offerings
7.2.4 Teva Pharmaceutical Industries Idiopathic Hypersomnia Treatment Revenue in Global Market (2018-2023)
7.2.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.3 Jazz Pharmaceuticals
7.3.1 Jazz Pharmaceuticals Company Summary
7.3.2 Jazz Pharmaceuticals Business Overview
7.3.3 Jazz Pharmaceuticals Idiopathic Hypersomnia Treatment Major Product Offerings
7.3.4 Jazz Pharmaceuticals Idiopathic Hypersomnia Treatment Revenue in Global Market (2018-2023)
7.3.5 Jazz Pharmaceuticals Key News & Latest Developments
7.4 BIOPROJET
7.4.1 BIOPROJET Company Summary
7.4.2 BIOPROJET Business Overview
7.4.3 BIOPROJET Idiopathic Hypersomnia Treatment Major Product Offerings
7.4.4 BIOPROJET Idiopathic Hypersomnia Treatment Revenue in Global Market (2018-2023)
7.4.5 BIOPROJET Key News & Latest Developments
7.5 Avadel Pharmaceuticals
7.5.1 Avadel Pharmaceuticals Company Summary
7.5.2 Avadel Pharmaceuticals Business Overview
7.5.3 Avadel Pharmaceuticals Idiopathic Hypersomnia Treatment Major Product Offerings
7.5.4 Avadel Pharmaceuticals Idiopathic Hypersomnia Treatment Revenue in Global Market (2018-2023)
7.5.5 Avadel Pharmaceuticals Key News & Latest Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Idiopathic Hypersomnia Treatment Major Product Offerings
7.6.4 GlaxoSmithKline Idiopathic Hypersomnia Treatment Revenue in Global Market (2018-2023)
7.6.5 GlaxoSmithKline Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Idiopathic Hypersomnia Treatment Major Product Offerings
7.7.4 Pfizer Idiopathic Hypersomnia Treatment Revenue in Global Market (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 Theranexus
7.8.1 Theranexus Company Summary
7.8.2 Theranexus Business Overview
7.8.3 Theranexus Idiopathic Hypersomnia Treatment Major Product Offerings
7.8.4 Theranexus Idiopathic Hypersomnia Treatment Revenue in Global Market (2018-2023)
7.8.5 Theranexus Key News & Latest Developments
7.9 Fisher and Paykel Healthcare
7.9.1 Fisher and Paykel Healthcare Company Summary
7.9.2 Fisher and Paykel Healthcare Business Overview
7.9.3 Fisher and Paykel Healthcare Idiopathic Hypersomnia Treatment Major Product Offerings
7.9.4 Fisher and Paykel Healthcare Idiopathic Hypersomnia Treatment Revenue in Global Market (2018-2023)
7.9.5 Fisher and Paykel Healthcare Key News & Latest Developments
7.10 Drive DeVilbiss Healthcare
7.10.1 Drive DeVilbiss Healthcare Company Summary
7.10.2 Drive DeVilbiss Healthcare Business Overview
7.10.3 Drive DeVilbiss Healthcare Idiopathic Hypersomnia Treatment Major Product Offerings
7.10.4 Drive DeVilbiss Healthcare Idiopathic Hypersomnia Treatment Revenue in Global Market (2018-2023)
7.10.5 Drive DeVilbiss Healthcare Key News & Latest Developments
7.11 Merck
7.11.1 Merck Company Summary
7.11.2 Merck Business Overview
7.11.3 Merck Idiopathic Hypersomnia Treatment Major Product Offerings
7.11.4 Merck Idiopathic Hypersomnia Treatment Revenue in Global Market (2018-2023)
7.11.5 Merck Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Idiopathic Hypersomnia Treatment Market Opportunities & Trends in Global Market
Table 2. Idiopathic Hypersomnia Treatment Market Drivers in Global Market
Table 3. Idiopathic Hypersomnia Treatment Market Restraints in Global Market
Table 4. Key Players of Idiopathic Hypersomnia Treatment in Global Market
Table 5. Top Idiopathic Hypersomnia Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Idiopathic Hypersomnia Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Idiopathic Hypersomnia Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Idiopathic Hypersomnia Treatment Product Type
Table 9. List of Global Tier 1 Idiopathic Hypersomnia Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Idiopathic Hypersomnia Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Idiopathic Hypersomnia Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Idiopathic Hypersomnia Treatment Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Idiopathic Hypersomnia Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Idiopathic Hypersomnia Treatment Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Idiopathic Hypersomnia Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Idiopathic Hypersomnia Treatment Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2024-2030
Table 30. Takeda Pharmaceutical Company Summary
Table 31. Takeda Pharmaceutical Idiopathic Hypersomnia Treatment Product Offerings
Table 32. Takeda Pharmaceutical Idiopathic Hypersomnia Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Takeda Pharmaceutical Key News & Latest Developments
Table 34. Teva Pharmaceutical Industries Company Summary
Table 35. Teva Pharmaceutical Industries Idiopathic Hypersomnia Treatment Product Offerings
Table 36. Teva Pharmaceutical Industries Idiopathic Hypersomnia Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Teva Pharmaceutical Industries Key News & Latest Developments
Table 38. Jazz Pharmaceuticals Company Summary
Table 39. Jazz Pharmaceuticals Idiopathic Hypersomnia Treatment Product Offerings
Table 40. Jazz Pharmaceuticals Idiopathic Hypersomnia Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Jazz Pharmaceuticals Key News & Latest Developments
Table 42. BIOPROJET Company Summary
Table 43. BIOPROJET Idiopathic Hypersomnia Treatment Product Offerings
Table 44. BIOPROJET Idiopathic Hypersomnia Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. BIOPROJET Key News & Latest Developments
Table 46. Avadel Pharmaceuticals Company Summary
Table 47. Avadel Pharmaceuticals Idiopathic Hypersomnia Treatment Product Offerings
Table 48. Avadel Pharmaceuticals Idiopathic Hypersomnia Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Avadel Pharmaceuticals Key News & Latest Developments
Table 50. GlaxoSmithKline Company Summary
Table 51. GlaxoSmithKline Idiopathic Hypersomnia Treatment Product Offerings
Table 52. GlaxoSmithKline Idiopathic Hypersomnia Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. GlaxoSmithKline Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Idiopathic Hypersomnia Treatment Product Offerings
Table 56. Pfizer Idiopathic Hypersomnia Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Pfizer Key News & Latest Developments
Table 58. Theranexus Company Summary
Table 59. Theranexus Idiopathic Hypersomnia Treatment Product Offerings
Table 60. Theranexus Idiopathic Hypersomnia Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. Theranexus Key News & Latest Developments
Table 62. Fisher and Paykel Healthcare Company Summary
Table 63. Fisher and Paykel Healthcare Idiopathic Hypersomnia Treatment Product Offerings
Table 64. Fisher and Paykel Healthcare Idiopathic Hypersomnia Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Fisher and Paykel Healthcare Key News & Latest Developments
Table 66. Drive DeVilbiss Healthcare Company Summary
Table 67. Drive DeVilbiss Healthcare Idiopathic Hypersomnia Treatment Product Offerings
Table 68. Drive DeVilbiss Healthcare Idiopathic Hypersomnia Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Drive DeVilbiss Healthcare Key News & Latest Developments
Table 70. Merck Company Summary
Table 71. Merck Idiopathic Hypersomnia Treatment Product Offerings
Table 72. Merck Idiopathic Hypersomnia Treatment Revenue (US$, Mn) & (2018-2023)
Table 73. Merck Key News & Latest Developments
List of Figures
Figure 1. Idiopathic Hypersomnia Treatment Segment by Type in 2022
Figure 2. Idiopathic Hypersomnia Treatment Segment by Application in 2022
Figure 3. Global Idiopathic Hypersomnia Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Idiopathic Hypersomnia Treatment Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Idiopathic Hypersomnia Treatment Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Idiopathic Hypersomnia Treatment Revenue in 2022
Figure 8. By Type - Global Idiopathic Hypersomnia Treatment Revenue Market Share, 2018-2030
Figure 9. By Application - Global Idiopathic Hypersomnia Treatment Revenue Market Share, 2018-2030
Figure 10. By Type - Global Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Idiopathic Hypersomnia Treatment Revenue Market Share, 2018-2030
Figure 12. By Application - Global Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Idiopathic Hypersomnia Treatment Revenue Market Share, 2018-2030
Figure 14. By Region - Global Idiopathic Hypersomnia Treatment Revenue Market Share, 2018-2030
Figure 15. By Country - North America Idiopathic Hypersomnia Treatment Revenue Market Share, 2018-2030
Figure 16. US Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Idiopathic Hypersomnia Treatment Revenue Market Share, 2018-2030
Figure 20. Germany Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2030
Figure 21. France Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Idiopathic Hypersomnia Treatment Revenue Market Share, 2018-2030
Figure 28. China Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2030
Figure 32. India Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Idiopathic Hypersomnia Treatment Revenue Market Share, 2018-2030
Figure 34. Brazil Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Idiopathic Hypersomnia Treatment Revenue Market Share, 2018-2030
Figure 37. Turkey Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Idiopathic Hypersomnia Treatment Revenue, (US$, Mn), 2018-2030
Figure 41. Takeda Pharmaceutical Idiopathic Hypersomnia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Teva Pharmaceutical Industries Idiopathic Hypersomnia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Jazz Pharmaceuticals Idiopathic Hypersomnia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. BIOPROJET Idiopathic Hypersomnia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Avadel Pharmaceuticals Idiopathic Hypersomnia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. GlaxoSmithKline Idiopathic Hypersomnia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Pfizer Idiopathic Hypersomnia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Theranexus Idiopathic Hypersomnia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Fisher and Paykel Healthcare Idiopathic Hypersomnia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Drive DeVilbiss Healthcare Idiopathic Hypersomnia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Merck Idiopathic Hypersomnia Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
